A Normalized Spot-Sample Estimation of α-1 Antitrypsin Clearance: The Search for a Simpler Test in Protein Losing Enteropathy
Open Access
- 23 November 2025
- journal article
- research article
- Published by Georg Thieme Verlag KG in World Journal of Nuclear Medicine
- Vol. 24 (04) , 346-351
Abstract
Protein losing enteropathy (PLE) is usually a diagnosis of exclusion, which requires cumbersome tests to confirm. In the quest for a simpler diagnostic test, we hypothesized that a spot stool sample estimation of α-1 antitrypsin will be sufficient to make a diagnosis of PLE, if we control for serum α-1 antitrypsin concentration and degree of stool dilution. Consecutive patients with a clinical suspicion of PLE and who had been advised a scintigraphy study were recruited after getting informed consent. The study excluded patients less than 1 year of age, pregnant women, and those with a clinical suspicion of chronic pancreatitis. Serum α-1 antitrypsin, spot stool α-1 antitrypsin, and stool elastase was assessed in all the patients. The diagnostic value of the index test was estimated from the patients with positive scintigraphy scan compared with a negative scan, expressed as sensitivity and specificity and the area under the receiver operating characteristic curve (AUROC). A total of 33 patients underwent scintigraphy with a clinical suspicion of PLE. Twenty patients (60%) showed tracer activity in the gut suggestive of PLE. Spot stool α-1 antitrypsin below 0.26 mg/g had a sensitivity of 100% to rule out PLE; however, the specificity was only 46%. Spot stool α-1 antitrypsin/(serum α-1 antitrypsin * elastase) ratio performed similar to spot stool α-1 antitrypsin as a diagnostic test (AUROC: 0.814 [0.61–1.0] vs. 0.796 [0.54–1.0]). Random stool antitrypsin is a sensitive test for diagnosing PLE; however, it lacks specificity. Spot stool α-1 antitrypsin/(serum α-1 antitrypsin * stool elastase) does not provide any additional value in the diagnosis of this syndrome.Keywords
This publication has 15 references indexed in Scilit:
- Association between technetium-99 m albumin scintigraphy-based severity of protein-losing enteropathy and patient characteristics and laboratory dataAnnals of Nuclear Medicine, 2025
- Small intestinal mucosal abnormalities using video capsule endoscopy in intestinal lymphangiectasiaOrphanet Journal of Rare Diseases, 2023
- Confocal laser endomicroscopy tears up the mask of protein-losing enteropathyEndoscopy, 2023
- Endoscopic and Imaging Findings in Protein-losing EnteropathyJournal of Clinical Gastroenterology, 2012
- Evaluation of Performance of Measurement of Faecal α1-Antitrypsin Clearance and Technetium-99m Human Serum Albumin Scintigraphy in Protein-Losing EnteropathyDigestion, 2011
- Clinical practiceEuropean Journal of Pediatrics, 2010
- Case Report: Fecal Clearance of α1-Antitrypsin with Lansoprazole Can Detect Protein-Losing GastropathyDigestive Diseases and Sciences, 1999
- α1-antitrypsin excretion in stool in normal subjects and in patients with gastrointestinal disordersGastroenterology, 1990
- lndium-111 Transferrin Imaging for the Diagnosis of Protein-Losing EnteropathyClinical Nuclear Medicine, 1989
- Simple method for diagnosing protein-losing enteropathies.BMJ, 1977